The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 254.67
-1.52 (-0.59%)
At close: Oct 22, 2026
The Arab Drug Company Financials Overview
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 1,370 | 1,370 | 1,118 | 785.52 | 633.73 | 505.04 |
Revenue Growth | 22.55% | 22.55% | 42.35% | 23.95% | 25.48% | -5.96% |
Gross Profit Gross Profit Growth | 524.91 | 524.91 | 466.28 | 265.99 | 224.35 | 185.43 |
Operating Income Operating Income Growth | 377.7 | 377.7 | 311.87 | 118.1 | 97.08 | 90.77 |
Net Income Net Income Growth | 232.38 | 232.38 | 204.86 | 88.35 | 71.13 | 76.3 |
Earnings Per Share EPS Growth | 19.37 | 19.37 | 17.07 | 7.36 | 5.93 | 5.63 |
EPS Growth | 13.43% | 13.43% | 131.89% | 24.21% | 5.28% | -23.14% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 119.73 | 119.73 | 79.28 | 232.72 | 50.48 | 40.28 |
Total Debt Total Debt Growth | 560.26 | 560.26 | 512.16 | 517.09 | 192.07 | 151.07 |
Net Cash (Debt) Net Cash Growth | -440.53 | -440.53 | -432.88 | -284.38 | -141.59 | -110.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -36.71 | -36.71 | -36.07 | -23.70 | -11.80 | -8.18 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 259.24 | 259.24 | 164.28 | 135.77 | 87.51 | 32.87 |
Capital Expenditures CapEx Growth | -116.72 | -116.72 | -198.9 | -285.98 | -63.18 | -89.92 |
Free Cash Flow Free Cash Flow Growth | 142.51 | 142.51 | -34.63 | -150.22 | 24.33 | -57.04 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 38.31% | 38.31% | 41.70% | 33.86% | 35.40% | 36.72% |
Operating Margin | 27.56% | 27.56% | 27.89% | 15.04% | 15.32% | 17.97% |
Pretax Margin | 25.00% | 25.00% | 26.36% | 16.88% | 16.84% | 19.46% |
Profit Margin | 16.96% | 16.96% | 18.32% | 11.25% | 11.22% | 15.11% |
FCF Margin | 10.40% | 10.40% | -3.10% | -19.12% | 3.84% | -11.29% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.167 | 4.175 | 2.250 | 2.400 |
Dividend Per Share Growth | 99.59% | 20.00% | -0.20% | 85.56% | -6.25% | -4.00% |
Dividend Yield | 1.96% | 2.08% | 4.14% | 10.39% | 6.73% | 10.47% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 13.15 | 12.42 | 5.90 | 5.46 | 5.64 | 3.61 |
Forward PE | - | 8.58 | 8.58 | 8.58 | 8.58 | 8.58 |
P/FCF Ratio | 21.44 | 20.25 | - | - | 16.49 | - |
PS Ratio | 2.23 | 2.11 | 1.08 | 0.61 | 0.63 | 0.55 |